EMFO, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
EMFO, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,332
-22.5%
3900.0%0.01%
-14.3%
Q2 2023$15,905
+9.4%
3900.0%0.01%0.0%
Q1 2023$14,536
+6.8%
3900.0%0.01%0.0%
Q4 2022$13,607
-38.2%
3900.0%0.01%
-33.3%
Q3 2022$22,000
+10.0%
3900.0%0.02%
+5.0%
Q2 2022$20,000
-28.6%
3900.0%0.02%
-20.0%
Q1 2022$28,000
-39.1%
3900.0%0.02%
-39.0%
Q4 2021$46,000
-11.5%
3900.0%0.04%
-10.9%
Q3 2021$52,000
-17.5%
3900.0%0.05%
-16.4%
Q2 2021$63,0003900.06%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 744,160$54,078,0005.79%
Discovery Value Fund 986,173$71,665,0005.28%
Ally Bridge Group (NY) LLC 60,000$4,360,0003.23%
MPM BioImpact LLC 159,409$11,584,0003.11%
ARK Investment Management 8,981,029$652,651,0002.72%
Elmwood Wealth Management, Inc. 67,599$4,912,0002.52%
Nikko Asset Management Americas, Inc. 2,872,269$192,442,0001.41%
Frazier Life Sciences Management, L.P. 203,684$14,802,0001.26%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$8,098,0001.22%
Merlin Capital, Inc 11,575$841,0001.11%
View complete list of INTELLIA THERAPEUTICS INC shareholders